Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON
  1. Startseite
  2. Aktien
  3. Deutschland
  4. Xetra
  5. Merck KGaA
  6. News
  7. Andere Sprachen
    MRK   DE0006599905   659990

MERCK KGAA

(659990)
  Bericht
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-NewsMarketScreener Analysen
Nachrichten in anderen Sprachen über MERCK KGAA
22.10.MERCK : Moody's Raises Merck KGaA's Rating to A3 on Improved Business Profile
21.10.MARKETMIND : Back to the blues
20.10.CytoReason Collaborates with Merck KGaA on Cancer Immunotherapy Drug
20.10.MARKETMIND : Margin pressures
19.10.MARKETMIND : Fast and furious
14.10.MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German Securities..
14.10.MERCK : EMD Serono, Inc. - New Real-World MAVENCLAD Data Show Sustained Effectiveness and ..
13.10.Merck KGaA's Multiple Sclerosis Treatment Drug Shows Improved Quality Of Life In Study
13.10.La energía se dispara, las acciones no tanto
12.10.MERCK : Opens Second Facility In California, US, With $115 Million Investment
12.10.MERCK : MilliporeSigma Announces Completion of New Viral Vector Contract Development Manuf..
06.10.MARKETMIND : Hunker down, it's going to be one of those days
06.10.CORRECTION : Merck KGaA Agrees to License CRISPR Technology to Genomics Group Cellecta
05.10.MERCK : Licenses CRISPR Technology To Genome Group Cellecta
04.10.MARKETMIND : Emerging Britain
04.10.MERCK KGAA : recrutement d'essais cliniques pour le RMS
04.10.MERCK : Completes Enrollment In Late-Stage Multiple Sclerosis Drug Trial
04.10.MERCK : UK Reviewing COVID-19 Drug Options, Including Merck's Molnupiravir
01.10.MARKETMIND : Final Quarter Blues
01.10.UK midcaps end at two-month lows in dour start to new quarter
30.09.ADRs Close Mostly Lower; AstraZeneca, Diageo Trade Actively
30.09.GLAXOSMITHKLINE : Merck KGaA, GlaxoSmithKline Terminate Agreement to Develop Bintrafusp Al..
30.09.MERCK : GSK end partnership on former cancer drug hopeful
30.09.MERCK : Mutually Terminates Agreement On Cancer Drug With GSK
30.09.Correction to Merck, GlaxoSmithKline Article
30.09.Merck KGaA, GlaxoSmithKline Terminate Agreement on Cancer Drug Development
29.09.MERCK : Interim Chief Information Officer Takes On Permanent Role
29.09.MARKETMIND : When it rains, it pours
28.09.MARKETMIND : Time to expect inflation
28.09.Artios Doses First Patient in Phase 1/2a Study of Pol? Inhibitor ART4215
28.09.MERCK : CIRCA GROUP'S BIO-BASED CHEMICALS FEATURED IN MERCK KGaA WEBINAR
24.09.Merck KGaA english
24.09.MARKETMIND : Move over Evergrande, time to watch soaring bond yields
23.09.MARKETMIND : E-Day and central banks galore
22.09.MERCK : Names Head of Newly-Created Group Communications, Brand and Corporate Affairs Divi..
22.09.MARKETMIND : Some relief - but how long will it last?
21.09.Nektar Therapeutics Shares Rise 5% on Deal With Pfizer, Merck KGaA
21.09.NEKTAR THERAPEUTICS : Partners With Pfizer, Merck for Clinical Trial
21.09.MERCK : Opens $33 Million Production Line For Silica-based Effect Pigments In Germany
21.09.MARKETMIND : Losing the plot
20.09.MERCK KGAA : des investissements soutenus dans l'électronique
20.09.EUROPEAN MIDDAY BRIEFING : Stocks Slump on China Fears
20.09.MERCK : Plans Over $3.5 Billion Investment By 2025 To Grow Electronics Business Sector
20.09.Merck KGaA to Invest More Than $3.5 Billion in Electronics Business
20.09.MARKETMIND : Watch those spiralling gas prices
17.09.MERCK : Agilyx AS (AGLX) - MilliporeSigma Joins Cyclyx as Founding Member
17.09.Reajustes en la industria de vacunas de la UE ante temor por escasez de suministros
17.09.MERCK : Trade Limitations Force Vaccine Producers To Rethink Supply Chain
17.09.MARKETMIND : Evergrande worries? Not really
16.09.MERCK KGAA : Release according to -4-
16.09.MERCK KGAA : Release according to -3-
16.09.MERCK KGAA : Release according to -2-
16.09.MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German Securities..
16.09.BIOCORP : accord avec Merck pour une version de Mallya
16.09.BIOCORP : partenariat avec Merck
16.09.MERCK KGAA : accord avec Biocorp dans l'hormone de croissance
14.09.MERCK KGAA : Release according to -4-
14.09.MERCK KGAA : Release according to -3-
14.09.MERCK KGAA : Release according to -2-
14.09.MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German Securities..
14.09.MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German Securities..
14.09.MERCK : Group CFO Presentation
14.09.ANALYST RECOMMENDATIONS : Apple, Bank of America, Cisco, DT Midstream, Halliburton...
14.09.MERCK KGAA : plus forte baisse du DAX, une dégradation pèse
14.09.OPINIONES DE ANALISTAS DEL DÍA : Inditex, Técnicas Reunidas, STMicroelectronics, Delivery ..
14.09.MARKETMIND : Pandeconomics part 2
14.09.AVIS D'ANALYSTES DU JOUR : STMicroelectronics, Delivery Hero, Sanlorenzo, Tecan, Carlsberg..
13.09.MARKETMIND : September setback
13.09.OPINIONES DE LOS ANALISTAS DEL DÍA : Acciona, BMW, Allianz, Getlink, Rio Tinto, Polypeptid..
13.09.AVIS D'ANALYSTES DU JOUR : BMW, Allianz, Getlink, Ubisoft, Neoen, Polypeptide, Verbund...
10.09.Biden busca retomar el control
10.09.MARKETMIND : Hitting the buffers
10.09.Biden cherche à reprendre la main
10.09.AVIS D'ANALYSTES DU JOUR : LVMH, BNP Paribas, Fresenius, SAM Solar, Dormakaba, Somfy, Char..
09.09.MARCHÉS : Wall Street attend, l'Europe digère bien la BCE
1  2  3  4  5  6  7  8  9  10Weiter
Anstehende Termine für MERCK KGAA